BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 19457128)

  • 1. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.
    Moriguchi S; Han F; Shioda N; Yamamoto Y; Nakajima T; Nakagawasai O; Tadano T; Yeh JZ; Narahashi T; Fukunaga K
    J Neurochem; 2009 Jul; 110(1):170-81. PubMed ID: 19457128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice.
    Moriguchi S; Han F; Nakagawasai O; Tadano T; Fukunaga K
    J Neurochem; 2006 Apr; 97(1):22-9. PubMed ID: 16515554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized mice.
    Han F; Nakano T; Yamamoto Y; Shioda N; Lu YM; Fukunaga K
    Brain Res; 2009 Apr; 1265():205-14. PubMed ID: 19233146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.
    Moriguchi S; Yamamoto Y; Ikuno T; Fukunaga K
    J Neurochem; 2011 Jun; 117(5):879-91. PubMed ID: 21434925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaM kinase II and protein kinase C activations mediate enhancement of long-term potentiation by nefiracetam in the rat hippocampal CA1 region.
    Moriguchi S; Shioda N; Han F; Narahashi T; Fukunaga K
    J Neurochem; 2008 Aug; 106(3):1092-103. PubMed ID: 18445137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel nootropic drug sunifiram improves cognitive deficits via CaM kinase II and protein kinase C activation in olfactory bulbectomized mice.
    Moriguchi S; Tanaka T; Tagashira H; Narahashi T; Fukunaga K
    Behav Brain Res; 2013 Apr; 242():150-7. PubMed ID: 23295391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/calmodulin kinase II and protein kinase C in mouse hippocampus.
    Han F; Shioda N; Moriguchi S; Yamamoto Y; Raie AY; Yamaguchi Y; Hino M; Fukunaga K
    J Pharmacol Exp Ther; 2008 Jul; 326(1):127-34. PubMed ID: 18388258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation.
    Moriguchi S; Shioda N; Han F; Yeh JZ; Narahashi T; Fukunaga K
    Hippocampus; 2009 Sep; 19(9):844-54. PubMed ID: 19253410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaMKII activity is essential for improvement of memory-related behaviors by chronic rivastigmine treatment.
    Moriguchi S; Tagashira H; Sasaki Y; Yeh JZ; Sakagami H; Narahashi T; Fukunaga K
    J Neurochem; 2014 Mar; 128(6):927-37. PubMed ID: 24164423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domoic acid induces a long-lasting enhancement of CA1 field responses and impairs tetanus-induced long-term potentiation in rat hippocampal slices.
    Qiu S; Jebelli AK; Ashe JH; CurrĂ¡s-Collazo MC
    Toxicol Sci; 2009 Sep; 111(1):140-50. PubMed ID: 19564213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor.
    Moriguchi S; Shioda N; Maejima H; Zhao X; Marszalec W; Yeh JZ; Fukunaga K; Narahashi T
    Mol Pharmacol; 2007 Feb; 71(2):580-7. PubMed ID: 17095583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation.
    Yamamoto Y; Shioda N; Han F; Moriguchi S; Nakajima A; Yokosuka A; Mimaki Y; Sashida Y; Yamakuni T; Ohizumi Y; Fukunaga K
    Brain Res; 2009 Oct; 1295():218-29. PubMed ID: 19646972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic nicotine-induced switch in Src-family kinase signaling for long-term potentiation induction in hippocampal CA1 pyramidal cells.
    Yamazaki Y; Jia Y; Wong JK; Sumikawa K
    Eur J Neurosci; 2006 Dec; 24(11):3271-84. PubMed ID: 17156388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II.
    Watson JB; Khorasani H; Persson A; Huang KP; Huang FL; O'Dell TJ
    J Neurosci Res; 2002 Nov; 70(3):298-308. PubMed ID: 12391589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice.
    Moriguchi S; Yabuki Y; Fukunaga K
    J Neurochem; 2012 Feb; 120(4):541-51. PubMed ID: 22136399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor-induced synaptic facilitation is associated with increased calcium/calmodulin-dependent protein kinase II, protein kinase C and extracellular signal-regulated kinase activities in the rat hippocampal CA1 region.
    Moriguchi S; Shioda N; Yamamoto Y; Fukunaga K
    Neuroscience; 2010 Apr; 166(4):1158-66. PubMed ID: 20074623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory consolidation induces N-methyl-D-aspartic acid-receptor- and Ca2+/calmodulin-dependent protein kinase II-dependent modifications in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor properties.
    Bevilaqua LR; Medina JH; Izquierdo I; Cammarota M
    Neuroscience; 2005; 136(2):397-403. PubMed ID: 16182449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+/calmodulin-dependent protein kinase II and protein kinase C activities mediate extracellular glucose-regulated hippocampal synaptic efficacy.
    Moriguchi S; Oomura Y; Shioda N; Han F; Hori N; Aou S; Fukunaga K
    Mol Cell Neurosci; 2011 Jan; 46(1):101-7. PubMed ID: 20807573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation.
    Zhao D; Watson JB; Xie CW
    J Neurophysiol; 2004 Nov; 92(5):2853-8. PubMed ID: 15212428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+/calmodulin-dependent protein kinase II-dependent long-term potentiation in the rat suprachiasmatic nucleus and its inhibition by melatonin.
    Fukunaga K; Horikawa K; Shibata S; Takeuchi Y; Miyamoto E
    J Neurosci Res; 2002 Dec; 70(6):799-807. PubMed ID: 12444602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.